XTalks

JANUARY 19, 2024

This biological variability adds complexity, but with that complexity comes the power to choose the targets, the tags and the payloads and select combinations appropriate to the patient to personalize that therapy. There is also potential for using several radiotherapies in combination therapies. References The Green Journal.

DNA 66

DNA Radiology FDA Approval Development 66

Pharmaceutical Technology

NOVEMBER 30, 2022

We are calling this the ‘medical bypass’,” says Dr. Dimitris Papamargaritis, an associate professor and honorary consultant in diabetes and endocrinology at the University of Leicester. “We’re using a combination of gut hormones to mimic the effectiveness of bariatric surgery. Anti-obesity therapeutic landscape. compared to a 5.1%

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

We are calling this the ‘medical bypass’,” says Dr. Dimitris Papamargaritis, an associate professor and honorary consultant in diabetes and endocrinology at the University of Leicester. “We’re using a combination of gut hormones to mimic the effectiveness of bariatric surgery. Anti-obesity therapeutic landscape. compared to a 5.1%

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246